nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—Melatonin metabolism and effects—EDN1—melanoma	0.0172	0.0172	CbGpPWpGaD
Pralidoxime—ACHE—Glycerophospholipid biosynthesis—GPAM—melanoma	0.0162	0.0162	CbGpPWpGaD
Pralidoxime—ACHE—Melatonin metabolism and effects—PRKCA—melanoma	0.0162	0.0162	CbGpPWpGaD
Pralidoxime—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—melanoma	0.0158	0.0158	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—ITGB3—melanoma	0.0149	0.0149	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIP4K2A—melanoma	0.0145	0.0145	CbGpPWpGaD
Pralidoxime—BCHE—Glycerophospholipid biosynthesis—GPAM—melanoma	0.0144	0.0144	CbGpPWpGaD
Pralidoxime—ACHE—Glycerophospholipid biosynthesis—PLA2G6—melanoma	0.0138	0.0138	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIP4K2A—melanoma	0.0129	0.0129	CbGpPWpGaD
Pralidoxime—BCHE—Glycerophospholipid biosynthesis—PLA2G6—melanoma	0.0123	0.0123	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—GPAM—melanoma	0.0113	0.0113	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.0111	0.0111	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—PAX6—melanoma	0.0108	0.0108	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—SLC6A11—melanoma	0.0107	0.0107	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—GPAM—melanoma	0.0101	0.0101	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—PAX6—melanoma	0.00961	0.00961	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PLA2G6—melanoma	0.0096	0.0096	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00958	0.00958	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—PDGFRA—melanoma	0.00925	0.00925	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—PRKCA—melanoma	0.00915	0.00915	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.00898	0.00898	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PLA2G6—melanoma	0.00856	0.00856	CbGpPWpGaD
Pralidoxime—ACHE—Melatonin metabolism and effects—NFKB1—melanoma	0.00834	0.00834	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—SLC6A11—melanoma	0.00823	0.00823	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.00801	0.00801	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.00801	0.00801	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00768	0.00768	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CDK4—melanoma	0.00762	0.00762	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—NOS2—melanoma	0.0074	0.0074	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.0074	0.0074	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC6A11—melanoma	0.00734	0.00734	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.00718	0.00718	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00685	0.00685	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.00681	0.00681	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PIGU—melanoma	0.00664	0.00664	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ADAMTS20—melanoma	0.00664	0.00664	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—RB1—melanoma	0.00662	0.00662	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00656	0.00656	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MMP2—melanoma	0.00635	0.00635	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ARL2—melanoma	0.00607	0.00607	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—TNF—melanoma	0.006	0.006	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ADAMTS20—melanoma	0.00592	0.00592	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PIGU—melanoma	0.00592	0.00592	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00585	0.00585	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—BCL2—melanoma	0.00573	0.00573	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IFNG—melanoma	0.00568	0.00568	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ARL2—melanoma	0.00542	0.00542	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CXCL8—melanoma	0.00528	0.00528	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIN2A—melanoma	0.00503	0.00503	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CCND1—melanoma	0.00492	0.00492	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—IGF1—melanoma	0.0049	0.0049	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00465	0.00465	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIN2A—melanoma	0.00449	0.00449	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—SLC17A5—melanoma	0.00443	0.00443	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—IGF1—melanoma	0.00437	0.00437	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ADAMTS13—melanoma	0.00428	0.00428	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00415	0.00415	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK3—melanoma	0.00406	0.00406	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00398	0.00398	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—SLC17A5—melanoma	0.00395	0.00395	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.00389	0.00389	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00388	0.00388	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK1—melanoma	0.00386	0.00386	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ADAMTS13—melanoma	0.00382	0.00382	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00373	0.00373	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.00365	0.00365	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—CTNNB1—melanoma	0.00364	0.00364	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CG—melanoma	0.00363	0.00363	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00363	0.00363	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.00361	0.00361	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.00358	0.00358	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00351	0.00351	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00347	0.00347	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PRKCA—melanoma	0.00345	0.00345	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.00344	0.00344	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ACER3—melanoma	0.00342	0.00342	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00338	0.00338	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.00332	0.00332	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—CTNNB1—melanoma	0.00324	0.00324	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CG—melanoma	0.00324	0.00324	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00324	0.00324	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CD—melanoma	0.00319	0.00319	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS3—melanoma	0.00319	0.00319	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.00315	0.00315	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UGT2B10—melanoma	0.00313	0.00313	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00309	0.00309	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PRKCA—melanoma	0.00308	0.00308	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACER3—melanoma	0.00305	0.00305	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.00299	0.00299	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.00298	0.00298	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IL6—melanoma	0.00297	0.00297	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HS3ST5—melanoma	0.00291	0.00291	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CD—melanoma	0.00285	0.00285	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS3—melanoma	0.00285	0.00285	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.0028	0.0028	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UGT2B10—melanoma	0.00279	0.00279	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CB—melanoma	0.00278	0.00278	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00277	0.00277	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00276	0.00276	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PRKCA—melanoma	0.00264	0.00264	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00261	0.00261	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HS3ST5—melanoma	0.0026	0.0026	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.00257	0.00257	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—BRAF—melanoma	0.00254	0.00254	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CB—melanoma	0.00248	0.00248	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00248	0.00248	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PTEN—melanoma	0.00241	0.00241	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.00236	0.00236	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PRKCA—melanoma	0.00236	0.00236	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00234	0.00234	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—BRAF—melanoma	0.00226	0.00226	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.00224	0.00224	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.00221	0.00221	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLCB4—melanoma	0.0022	0.0022	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.00218	0.00218	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00216	0.00216	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PTEN—melanoma	0.00215	0.00215	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00213	0.00213	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—MDM2—melanoma	0.00213	0.00213	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00209	0.00209	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC6A11—melanoma	0.00207	0.00207	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIP4K2A—melanoma	0.00207	0.00207	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PAX6—melanoma	0.00203	0.00203	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTAP—melanoma	0.00202	0.00202	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.00201	0.00201	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00197	0.00197	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00197	0.00197	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLCB4—melanoma	0.00197	0.00197	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—HSPA5—melanoma	0.00195	0.00195	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—BRAF—melanoma	0.00194	0.00194	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00193	0.00193	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.00192	0.00192	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.0019	0.0019	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MDM2—melanoma	0.0019	0.0019	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00186	0.00186	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.00185	0.00185	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC6A11—melanoma	0.00185	0.00185	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIP4K2A—melanoma	0.00185	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.00185	0.00185	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PAX6—melanoma	0.00181	0.00181	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTAP—melanoma	0.0018	0.0018	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PHGDH—melanoma	0.0018	0.0018	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LUM—melanoma	0.0018	0.0018	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HPSE—melanoma	0.00176	0.00176	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00176	0.00176	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—HSPA5—melanoma	0.00174	0.00174	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—BRAF—melanoma	0.00173	0.00173	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CUBN—melanoma	0.00173	0.00173	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CA—melanoma	0.0017	0.0017	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.00168	0.00168	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CSPG4—melanoma	0.00167	0.00167	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—BSG—melanoma	0.00167	0.00167	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SDHD—melanoma	0.00167	0.00167	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MDM2—melanoma	0.00163	0.00163	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPAM—melanoma	0.00162	0.00162	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LUM—melanoma	0.0016	0.0016	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PHGDH—melanoma	0.0016	0.0016	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.00158	0.00158	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HPSE—melanoma	0.00157	0.00157	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CUBN—melanoma	0.00154	0.00154	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.00154	0.00154	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CA—melanoma	0.00151	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.00151	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.00151	0.00151	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SDHD—melanoma	0.00149	0.00149	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CSPG4—melanoma	0.00149	0.00149	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—BSG—melanoma	0.00149	0.00149	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MDM2—melanoma	0.00145	0.00145	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—MAPK1—melanoma	0.00145	0.00145	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPAM—melanoma	0.00144	0.00144	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.00144	0.00144	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.00142	0.00142	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLA2G6—melanoma	0.00138	0.00138	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.00131	0.00131	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	0.0013	0.0013	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.00127	0.00127	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—VCAN—melanoma	0.00124	0.00124	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLA2G6—melanoma	0.00123	0.00123	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.00117	0.00117	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—HRAS—melanoma	0.00117	0.00117	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP1—melanoma	0.00116	0.00116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00113	0.00113	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MAPK1—melanoma	0.00111	0.00111	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—VCAN—melanoma	0.0011	0.0011	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.00107	0.00107	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.00104	0.00104	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP17A1—melanoma	0.00104	0.00104	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	0.00104	0.00104	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP1—melanoma	0.00103	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.00103	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—melanoma	0.00102	0.00102	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00101	0.00101	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MAPK1—melanoma	0.000994	0.000994	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GNA11—melanoma	0.000985	0.000985	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FASN—melanoma	0.000964	0.000964	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC5A5—melanoma	0.000948	0.000948	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP17A1—melanoma	0.00093	0.00093	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF1—melanoma	0.000926	0.000926	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000917	0.000917	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GNAQ—melanoma	0.000915	0.000915	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CD44—melanoma	0.000915	0.000915	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000906	0.000906	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000896	0.000896	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP2—melanoma	0.000896	0.000896	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HRAS—melanoma	0.000894	0.000894	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000888	0.000888	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GNA11—melanoma	0.000878	0.000878	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP1B1—melanoma	0.000878	0.000878	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FASN—melanoma	0.00086	0.00086	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC5A5—melanoma	0.000846	0.000846	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF1—melanoma	0.000826	0.000826	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CD44—melanoma	0.000817	0.000817	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GNAQ—melanoma	0.000817	0.000817	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.0008	0.0008	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP2—melanoma	0.000799	0.000799	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HRAS—melanoma	0.000798	0.000798	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000792	0.000792	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP1B1—melanoma	0.000783	0.000783	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000775	0.000775	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CXCL8—melanoma	0.000744	0.000744	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCB1—melanoma	0.000723	0.000723	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000691	0.000691	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CTNNB1—melanoma	0.000687	0.000687	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PRKCA—melanoma	0.000665	0.000665	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CXCL8—melanoma	0.000664	0.000664	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ERCC2—melanoma	0.00066	0.00066	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCB1—melanoma	0.000645	0.000645	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CTNNB1—melanoma	0.000613	0.000613	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PRKCA—melanoma	0.000593	0.000593	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ERCC2—melanoma	0.000589	0.000589	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000546	0.000546	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CG—melanoma	0.000521	0.000521	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARG—melanoma	0.000503	0.000503	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000488	0.000488	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CG—melanoma	0.000465	0.000465	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CD—melanoma	0.000458	0.000458	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—melanoma	0.000452	0.000452	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARG—melanoma	0.000449	0.000449	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CD—melanoma	0.000409	0.000409	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—melanoma	0.000403	0.000403	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CB—melanoma	0.000399	0.000399	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—melanoma	0.000396	0.000396	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CB—melanoma	0.000356	0.000356	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—melanoma	0.000353	0.000353	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTEN—melanoma	0.000345	0.000345	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTEN—melanoma	0.000308	0.000308	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CA—melanoma	0.000243	0.000243	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CA—melanoma	0.000217	0.000217	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—melanoma	0.000199	0.000199	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—melanoma	0.000177	0.000177	CbGpPWpGaD
